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The selective assembly of functionalised fibres produced 
by wet-spinning into implantable three dimensional 
contructs presents attractive prospects for the field of 
medical bionics[1]. In particular, the incorporation of 
biological factors and large numbers of cells within 
biocompatible and macroporous fibres is expected to 
deliver improvements to drug delivery platforms as well 
as to tissue engineering biotechnology[2, 3]. 
 
Hydrogel class materials, in particular chitosan and 
sodium alginate, are suitable for soft tissue engineering 
applications due to their compliance with the physical 
properties of target tissues and permissive degradation 
profile that elicits minimal inflammatory response [4, 5]. 
The wet-spinning process allows for these materials to be 
deposited, woven or knitted into defined structures [6]. 
Thorough optimisation of novel processes for biomaterial 
fabrication is paramount, as the resulting devices and 
conduits become both more effective and reproducible 
with precision assembly[7]. 
 
OBJECTIVE 
This study assessed wet-spinning technology as a method 
for generating three dimensional soft gel fiber geometries 
biologically functionalized by incorporation of live cells. 
This was achieved through the analysis of process 
parameters, fibre dimension, as well as cell-loading, 
viability, position and alignment.   
  
Sodium alginate of varying concentrations was selected as 
a matrix material for the fibres. Primary myoblasts from 
C57BL10-ROSA mice were used for fabrication of 
regenerative muscle constructs, exploiting geometric 
compatibility between muscle structure linearity and wet-
spun fiber output. This process was developed into a an 
optimised methodology for reproducible production of 
fibres using this model, and a three dimensional myo-
regenerative conduit developed. 
 
APPROACH 
Materials. A buffer solution of 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES, Biochemical, 
#L505388) was made up to a concentration of 20mM  in a 
308mM sodium chloride (NaCl) solution. Alginic acid 
with sodium salt (Sigma, #035K0205) was made to 
concentrations of 2% and 4% (wt/v) at 60°C under 
stirring. A ROSA mouse myoblast cell line was grown to 
80% confluence in a series of thirty T-75 flasks in 20mL 
of Dulbecco's Modified Eagle's Medium (DMEM) at 
37°C. The cells were then trypsinised and centrifuged at 
280g for 2 minutes to pellet the cells. The cells were then 
resuspended in HEPES solution to concentrations of 20, 
40 and 60 millions cells/mL. Mixing with corresponding 
alginate solutions resulted in cell concentrations of 10, 20 
and 30 million cells/mL for both 1% and 2% (wt/v) 
alginate concentration.  
 
Wet Spinning. A wet spinning arrangement as described 
in Figure 1, was used to fabricate cell-impregnated 
alginate fibres. An aqueous coagulation bath (L=1m) of 
2% calcium chloride (Sigma, #48H0106) was utilised in 
cross-linking the fibres. Solutions were extruded into a 
coagulation bath using a high precision KD Scientific 
KDS-410 constant volume syringe pump at a rate of 
0.03mL/min (32G nozzle - EFD Nordson). A rotating 
drum was operated at a fixed velocity of 2cm/s for the 
collection of fibres following coagulation.  
 
 
Figure 1: Basis of the wet-spinning process, adapted from 
Ruijter et al.[8] 
Analysis. For viability , fibres were collected into HEPES 
containing 1µM calcein AM in DMSO and 1µg/mL of 
propidium iodide (PI). An Olympus IX70 fluorescence 
microscope was used at 10x to observe cell viability and 
fibre dimension (n>3). For cryoslicing, fibres were 
embedded into Tissue-Tek Optimal Cutting Temperature 
Compound and placed into a slurry of dry ice and ethanol. 
These were stored at -70°C before being sliced using a 
LEICA CM1900 Rapid Sectioning Cryostat. Four 
independent experiments were carried out to ensure the 
repeatability of the fabrication process. Finally, several 
fibres were collected into both proliferation and 
differentiation media for observation.  
 
RESULTS AND DISCUSSION 
Each of the cell loadings tested were successfully 
fabricated repeatedly into fibres of both 1% and 2% 
alginate matrices (Figure 2). Through optimisation of the 
material feed rate and handling methods, large quantities 
of cell laden fibres could be manufactured. While there 
were minor differences in the fibre diameters observed 
(~130-150µm), the alginate concentration and cell 
loadings demonstrate no correlation to any significant 
differences in diameter (Figure 3).  
 
Figure 2: Alginate fibres (2% wt/v) impregnated with A) 10M 
cells/mL, B) 20M cells/mL, C) 30M cells/mL. 
 
Figure 3: Average fibre dimension with respect to cell and 
alginate concentration.  
Samples produced with 1% alginate and 20 million 
cells/mL showed the highest cell viability over the four 
experiements of 96 ± 1% (Figure 4).  
 
Figure 4: A) Cell formulation prespin. B) 1% alginate fibre 
containing 20M cells/mL. C) Same fibre under fluorescence, 
showing cell death through PI staining.  
Fibres produced using 2% alginate as a matrix material, 
while displaying similar fibre diameters, demonstrated a 
lowered  cell viability and consistency when compared to 
the 1% alginate fibres (Figure 5). Finally, in a preliminary 
attempt to produce a wet-spun, cell-laden three-
dimensional construct, a 5-layer, 1% alginate, 20M 
cells/mL mesh was produced through the continual 90° 
reorientation of the mounted collection substrate (Figure 
6).  
 
Figure 5: Comparison of cell viability for each tested subgroup 
over four independent experiments (n=4). A one-way ANOVA 
was applied to the data (*** for p<0.05, ** for p<0.01, * for 
p<0.001).  
 
Figure 6: Multi-layered, wet-spun mesh of 1% wt/v alginate 
containing 20M cells/mL. 
CONCLUSION 
This work communicates the successful fabrication of 
cell-laden fibres at high cell concentrations. The cells 
remain viable post-fabrication and it was determined that 
the most efficient subgroup consisted of a 1% wt/v 
alginate matrix incorporating a cell concentration of 20M 
cells/mL. A cell-loaded, three dimensional wet-spun 
scaffold was successfully produced.  
 
FUTURE WORK 
Future experimentation will integrate slow release growth 
factors and other biologically relevant agents such as anti-
inflammatory therapeutics into these systems. Cells of 
varying description should be fabricated into multi-
layered structures to meet specific three-dimensional 
tissue engineering requirements, and in vivo studies be 
carried out in animal models to observe cell migration and 
engraftment in target tissues such as muscle and nerve. 
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